» Articles » PMID: 1601607

Renal Tolerance of Gadolinium-DTPA/dimeglumine in Patients with Chronic Renal Failure

Overview
Journal Invest Radiol
Specialty Radiology
Date 1992 Feb 1
PMID 1601607
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Safety data for renal tolerance of gadolinium-DTPA(Gd-DTPA)/dimeglumine were evaluated in 21 patients (age: mean +/- standard deviation [SD], 58 +/- 12 years) with impaired renal function. The mean +/- SD serum creatinine level at baseline was 213 +/- 101 mumol/L (range, 89.2-551 mumol/L). Creatinine clearance at baseline averaged 34.5 +/- 19.2 mL/minute (range, 7.2-70 mL/minute). Gd-DTPA was injected at a dose of 0.1 mmol/kg body weight. Serum parameters (creatinine, sodium, and potassium) were determined before and 6, 24, 48, and 120 hours after administration of Gd-DTPA. Urinary parameters (N-acetyl-beta-D-glucosaminidase [beta-NAG], protein, and albumin) were determined before (spot urine sample) and after treatment for collection periods 0 to 3, 3 to 6, 6 to 12, 12 to 24, and 24 to 48 hours. A final spot urine sample was taken at 120 hours. There was no significant statistical change of serum creatinine level within the observation period, and there was no single patient matching the criteria of acute renal failure (increase of serum creatinine level of 88.4 mumol/L [1 mg/dL] or more within 48 hours after injection). Serum values of sodium and potassium levels remained unchanged. Beta-NAG was slightly increased 0 to 3 hours after injection, but returned to baseline values during the collection periods up to 120 hours. There was no increase of protein or albumin excretion. These preliminary results suggest Gd-DTPA has good renal tolerance in patients with pre-existing chronic renal failure.

Citing Articles

Magnetic resonance imaging for acute pancreatitis in type 2 diabetes patients.

Ni Y, Song L, Xiao B World J Clin Cases. 2023; 11(30):7268-7276.

PMID: 37969447 PMC: 10643067. DOI: 10.12998/wjcc.v11.i30.7268.


Current Concepts of Precancerous Lesions of Hepatocellular Carcinoma: Recent Progress in Diagnosis.

Liao Z, Tang C, Luo R, Gu X, Zhou J, Gao J Diagnostics (Basel). 2023; 13(7).

PMID: 37046429 PMC: 10093043. DOI: 10.3390/diagnostics13071211.


Cardiological Society of India practice guidelines for angiography in patients with renal dysfunction.

Bhandari S, Seth A, Sethi K, Tyagi S, Gupta R, Tiwari S Indian Heart J. 2012; 64 Suppl 2:S18-43.

PMID: 23186627 PMC: 4244816. DOI: 10.1016/j.ihj.2012.11.007.


Comparing Diagnostic Techniques of Magnetic Resonance Angiography (MRA) and Doppler Ultrasonography in Determining Severity of Renal Artery Stenosis.

Hashemi Jazi M, Arasteh M, Shamsolketabi H, Tavassoli A, Nilforoush P, Gharipour M ARYA Atheroscler. 2012; 7(2):58-62.

PMID: 22577447 PMC: 3347845.


Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis.

Ersoy H, Rybicki F J Magn Reson Imaging. 2007; 26(5):1190-7.

PMID: 17969161 PMC: 2709982. DOI: 10.1002/jmri.21135.